Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy

University of Kansas Specialized Chemistry Center, University of Kansas, Lawrence, KS 66047.
ACS Chemical Neuroscience (Impact Factor: 3.87). 01/2012; DOI: 10.1021/cn200128x

ABSTRACT Herein we present the outcome of a high throughput screening (HTS) campaign-based strategy for the rapid identifica-tion and optimization of selective and general chemotypes for both kappa (κ) opioid receptor (KOR) activation and inhibition. In this program, we have developed potent antagonists (IC 50 < 120 nM) or agonists of high binding affinity (K i < 3 nM). In contrast to many important KOR ligands, the compounds presented here are highly modular, readily synthesized, and, in most cases, achiral. The four new chemotypes hold promise for further development into chemical tools for studying the KOR or as potential therapeutic lead candidates. KEYWORDS: Kappa opioid receptor agonist, kappa opioid receptor antagonist, high-throughput screening T he kappa (κ) opioid receptor (KOR) regulates a wide

  • [Show abstract] [Hide abstract]
    ABSTRACT: The novel macrocyclic peptide cyclo[Phe-D-Pro-Phe-D-Trp] ([D-Trp]CJ-15,208) exhibits κ opioid receptor (KOR) antagonist activity in both in vitro and in vivo assays. The four alanine analogs of this peptide were synthesized and characterized both in vitro and in vivo to assess the contribution of different amino acid residues to the activity of [D-Trp]CJ-15,208. The peptides were synthesized by a combination of solid-phase peptide synthesis and cyclization in solution. The analogs were evaluated in vitro in receptor binding and functional assays, and in vivo with mice in the 55 (o) C warm water tail withdrawal assay for antinociceptive and opioid antagonist activity. Additional mice demonstrating extinction of cocaine conditioned place preference (CPP) were pretreated with selected analogs to evaluate prevention of stress or cocaine-induced reinstatement of CPP. The alanine analogs displayed pharmacological profiles in vivo that were distinctly different from [D-Trp]CJ,15,208. While the analogs exhibited varying opioid receptor affinities and KOR and MOR antagonist activity in vitro, they produced potent opioid receptor-mediated antinociception (ED50 = 0.28-4.19 nmol, i.c.v.) in vivo; three of the analogs also displayed KOR antagonist activity in vivo. Pretreatment with an analog exhibiting both KOR agonist and antagonist activity in vivo prevented both cocaine- and stress-induced reinstatement of cocaine-seeking behavior in the CPP assay in a time-dependent manner. These unusual macrocyclic peptides exhibit in vivo opioid activity profiles different from the parent compound and represent novel compounds for potential development as therapeutics for drug abuse and possibly as analgesics.
    British Journal of Pharmacology 03/2014; · 5.07 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Modification of the furan ring of salvinorin A (1), the main active component of Salvia divinorum, has resulted in novel neoclerodane diterpenes with opioid receptor affinity and activity. Conversion of the furan ring to an aldehyde at the C-12 position (5) has allowed for the synthesis of analogues with new carbon-carbon bonds at that position. Previous methods for forming these bonds, such as Grignard and Stille conditions, have met with limited success. We report a palladium catalyzed Liebeskind-Srogl cross-coupling reaction of a thioester and a boronic acid that occurs at neutral pH and ambient temperature to produce ketone analogs at C-12. To the best of our knowledge, this is the first reported usage of the Liebeskind-Srogl reaction to diversify a natural product scaffold. We also describe a one-step protocol for the conversion of 1 to 12-epi-1 (3) through microwave irradiation. Previously, this synthetically challenging process has required multiple steps. Additionally, we report in this study that alkene 9 and aromatic analogues 12, 19, 23, 25, and 26 were discovered to retain affinity and selectivity at kappa opioid receptors (KOP). Finally, we report that the furan-2-yl analog of 1 (31) has similar affinity to 1. Collectively, these findings suggest that different aromatic groups appended directly to the decalin core may be well tolerated by KOP receptors, and may generate further ligands with affinity and activity at KOP receptors.
    Bioorganic & medicinal chemistry 03/2012; 20(9):3100-10. · 2.82 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Graphical abstract Figure optionsDownload full-size imageDownload as PowerPoint slide
    Bioorganic & medicinal chemistry letters 01/2014; · 2.65 Impact Factor


Available from
May 23, 2014